Intra-abdominal infection due to gram-negative bacilli:an analysis of 478 cases
10.16718/j.1009-7708.2018.06.001
- VernacularTitle:腹腔内感染478例临床分析及病原菌分布
- Author:
Yuanyuan QIN
1
;
Wenxiang HUANG
;
Luole ZHAO
;
Yashu XU
;
Jiajun LI
;
Qing XIAO
Author Information
1. 重庆医科大学附属第一医院感染科
- Keywords:
gram-negative bacillus;
intra-abdominal infection;
antimicrobial susceptibility
- From:
Chinese Journal of Infection and Chemotherapy
2018;18(6):561-567
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the epidemiological and etiological characteristics of gram-negative bacilli (GNB) isolated from patients with intra-abdominal infection (IAI). Methods The patients with abdominal infection were identified retrospectively during the period from 2011 to 2015. The clinical and microbiological data were analyzed by WHONET 5.6 and SPSS 20.0. Results A total of 478 cases of IAI [hospital-acquired (HA) 290 cases, community-acquired (CA) 188 cases] were included in this analysis. CA-IAI patients at low risk were associated with significantly better outcome, and lower acute physiology and chronic health evaluation (APACHE) Ⅱ score and sequential organ failure assessment (SOFA) score than the CA-IAI and HA-IAI patients at high risk. The most common gram-negative bacillus isolated from intra-abdominal infections was E. coli and K. pneumoniae. The prevalence of ESBLs-producing E. coli and K. pneumoniae isolates was 75.8％ and 35.8％, respectively. The E. coli isolates remained highly susceptible to amikacin, piperacillin-tazobactam, and carbapenems during the 5-year period, while the K. pneumoniae isolates showed poorer susceptibility to ampicillin-sulbactam. Conclusions The prevalence of ESBLs-producing GNB is increasing in the patients with IAI. Such isolates were resistant to commonly used antimicrobial agents, but generally susceptible to carbapenems. It is important to strengthen the monitoring of antimicrobial resistance in IAIs, and choose antimicrobial therapy rationally based on the results of antimicrobial susceptibility test.
